Sanofi is battle-ready: "We welcome competition, not least from our great colleagues at Leo Pharma"

French pharmaceutical firm Sanofi has already spun gold within an area that Leo Pharma enters with major drug candidate.

Photo: Benoit Tessier/Reuters/Ritzau Scanpix

French pharmaceutical firm Sanofi has shown the way for the Danish pharmaceutical company Leo Pharma in terms of conquering the market for a new type of treatment for eczema and asthma.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs